Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV+ Patients”

Showing 20 of 0 results

Not applicableWithdrawnNCT00805857
What this trial is testing

Surveillance Cohort Long-term Toxicity Antiretrovirals in HIV-infected Patients Enrolled in TPV Cohort

Who this might be right for
HIV Infections
Boehringer Ingelheim
Not applicableLooking for participantsNCT03603977
What this trial is testing

Simplified Treatment of Anti-retrovirus in China (C-STAR)

Who this might be right for
HIV/AIDS
Guangzhou 8th People's Hospital 600
Testing effectiveness (Phase 2)UnknownNCT00002451
What this trial is testing

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 8
Not applicableStudy completedNCT06056037
What this trial is testing

Making ART Work Among Brazilian Youth

Who this might be right for
HivAdherence, Medication
Brown University 30
Not applicableStudy completedNCT02131571
What this trial is testing

Prevalence of Vertebral Fractures in HIV Infected Patients Older Than 50 Years

Who this might be right for
Vertebral Fractures
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 130
Large-scale testing (Phase 3)Study completedNCT01453192
What this trial is testing

Renal Transplantation and Raltegravir in HIV-Infected Patients

Who this might be right for
HIV-1 InfectionChronic Renal Insufficiency
ANRS, Emerging Infectious Diseases 27
Large-scale testing (Phase 3)Ended earlyNCT00440271
What this trial is testing

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

Who this might be right for
HIV Infections
Boehringer Ingelheim 33
Testing effectiveness (Phase 2)Study completedNCT00000644
What this trial is testing

A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Post-approval studies (Phase 4)WithdrawnNCT04183738
What this trial is testing

Inflammation and Co-Infections in D²EFT

Who this might be right for
HIV-infection/AidsHuman Herpesvirus 4 InfectionsCytomegalovirus Infections+2 more
Kirby Institute
Not applicableStudy completedNCT02276287
What this trial is testing

HIV Patients Illness Perception and Adherence

Who this might be right for
HIV
University of Milan 187
Not applicableStudy completedNCT00226304
What this trial is testing

Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma

Who this might be right for
HIV InfectionsLymphoma, AIDS-Related
National Institutes of Health Clinical Center (CC) 120
Post-approval studies (Phase 4)Study completedNCT00646984
What this trial is testing

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Hospital Clinic of Barcelona 147
Early research (Phase 1)Study completedNCT00002198
What this trial is testing

1592U89 and Ethanol When Given Together to HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00000747
What this trial is testing

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT06375304
What this trial is testing

The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study

Who this might be right for
HIV Infections
McGill University Health Centre/Research Institute of the McGill University Health Centre 50
Post-approval studies (Phase 4)Study completedNCT02383355
What this trial is testing

Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation

Who this might be right for
HIV
Radboud University Medical Center 40
Not applicableUnknownNCT00102934
What this trial is testing

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT00431548
What this trial is testing

Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)

Who this might be right for
HIV InfectionsRetinaOcular Physiology
Medical University of Vienna 30
Not applicableStudy completedNCT02196064
What this trial is testing

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."

Who this might be right for
Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects
Fundación Pública Andaluza Progreso y Salud 519
Large-scale testing (Phase 3)Study completedNCT02486133
What this trial is testing

Dual Therapy With Boosted Darunavir + Dolutegravir

Who this might be right for
HIV-Infection
Technical University of Munich 269
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation